NCT03583086 2024-10-08Phase I/II Eval Safety & Prelim Activity Nivolumab Comb W/Vorolanib Pts W/Refractory Thoracic TumorsVanderbilt-Ingram Cancer CenterPhase 1/2 Completed88 enrolled 20 charts
NCT04328506 2021-11-26Bioequivalency Study of CM082 Tablet in Healthy VolunteersAnewPharmaPhase 1 Completed96 enrolled
NCT04126668 2020-05-21A Study to Investigate the Food Effect on the Pharmacokinetics of CM082 Tablet in Chinese Healthy VolunteersAnewPharmaPhase 1 Completed24 enrolled
NCT01863485 2019-07-05Phase 1 Study of CM082 (X-82) Tablets in Advanced Cancer Patients in ChinaAnewPharmaPhase 1 Completed44 enrolled